Lv11
100 积分 2025-08-29 加入
Nerandomilast shatters decade-long stalemate in fibrotic lung diseases: FDA fast track insights
1个月前
已完结
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
1个月前
已完结
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
1个月前
已完结
Targeting the immunometabolism interface: A novel strategy for IPF therapy
1个月前
已完结
Therapeutic efficacy of pirfenidone and nintedanib in pulmonary fibrosis; a systematic review and meta-analysis
2个月前
已完结
Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: A recent update
2个月前
已完结
Advances in novel therapeutics for idiopathic pulmonary fibrosis
2个月前
已完结
Epithelial–mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease
2个月前
已完结
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis
2个月前
已完结
JTE-013 reduces inflammation and improves pulmonary fibrosis by regulating the TRAF2/NF - κB/IGF-1 signaling pathway and macrophage polarization
2个月前
已完结
皖公网安备34019202002308
